These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 18028805)

  • 21. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
    Sugihara T; Kobori A; Imaeda H; Tsujikawa T; Amagase K; Takeuchi K; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2010 Jun; 160(3):386-93. PubMed ID: 20089077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and significance of mucosal beta-defensin-2, TNFalpha and IL-1beta in ulcerative colitis].
    Chang YY; Ouyang Q
    Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):11-4. PubMed ID: 18346318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.
    Hollenbach E; Neumann M; Vieth M; Roessner A; Malfertheiner P; Naumann M
    FASEB J; 2004 Oct; 18(13):1550-2. PubMed ID: 15289440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of p38 MAPK in acute paraquat-induced lung injury in rats.
    Pei YH; Cai XM; Chen J; Sun BD; Sun ZR; Wang X; Qian XM
    Inhal Toxicol; 2014 Dec; 26(14):880-4. PubMed ID: 25357233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis.
    Lorén V; Cabré E; Ojanguren I; Domènech E; Pedrosa E; García-Jaraquemada A; Mañosa M; Manyé J
    PLoS One; 2015; 10(6):e0130921. PubMed ID: 26090671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
    Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
    Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The relationship between reactive oxygen species-dependent activation of p38 MAPK and the expression of tumor necrosis factor-α in cultured cardiomyocytes].
    Shang FJ; Wang JP; Zheng QS; Liu XT; Xue YS; Li J; Zhao LY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):7-10. PubMed ID: 21208554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interaction between p38 mitogen-activated protein kinase signal transduction pathway and NF-kappaB/IkappaB system on the proinflammatory cytokines release after burn trauma].
    Chen XL; Xia ZF; Wei D; Ben DF; Wang YJ; Deng NQ
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):492-5. PubMed ID: 16772089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P38 MAPK Pharmacological Inhibitor SB203580 Alleviates Total Parenteral Nutrition-Induced Loss of Intestinal Barrier Function but Promotes Hepatocyte Lipoapoptosis.
    Xiao YT; Yan WH; Cao Y; Yan JK; Cai W
    Cell Physiol Biochem; 2017; 41(2):623-634. PubMed ID: 28214831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation.
    Chen LW; Chen PH; Chang WJ; Wang JS; Karin M; Hsu CM
    Crit Care Med; 2007 May; 35(5):1332-40. PubMed ID: 17414734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the relationship between early growth response gene 1 activity in p38 mitogen-activated protein kinase pathway and epirubicin resistance of human breast carcinoma cells].
    Xiao L; Hu JL; Cui W
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):408-13. PubMed ID: 19781349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [SB203580 reduces proinflammatory cytokine production in rats after cardiopulmonary bypass].
    Dong X; Xu JJ; He X
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2168-70. PubMed ID: 19923057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.
    Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD
    Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats.
    Sun Y; Chen H; Ma S; Liang L; Zheng Y; Guo X; Wang M; Wang W; Li G; Zhong D
    Neurochem Res; 2015 Jul; 40(7):1410-20. PubMed ID: 25998885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox regulation of p38 MAPK activation and expression of ICAM-1 and heme oxygenase-1 in human alveolar epithelial (A549) cells.
    Bundy RE; Hoare GS; Kite A; Beach J; Yacoub M; Marczin N
    Antioxid Redox Signal; 2005; 7(1-2):14-24. PubMed ID: 15650392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
    Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes.
    Nguyen J; Gogusev J; Knapnougel P; Bauvois B
    Immunol Lett; 2006 Jul; 106(1):34-41. PubMed ID: 16720051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of p38 mitogen-activated protein kinase pathway ameliorates delayed intestinal transit in burned rats.
    Gan HT; Pasricha PJ; Chen JD
    Am J Surg; 2007 Apr; 193(4):530-7. PubMed ID: 17368305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia.
    Yin H; Zhang J; Lin H; Wang R; Qiao Y; Wang B; Liu F
    Inflammation; 2008 Apr; 31(2):65-73. PubMed ID: 17943427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.